DAT inhibitors (Contero Therapeutics)

N/A

Report date: 2025/03/18 18:16:46
NME

Base Information

Drug NameDAT inhibitors (Contero Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine transporter antagonists
TargetsDopamine transporter
Therapy Area/IndicationsFatigue
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesContero Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesContero Therapeutics
Inactive CompaniesN/A
Active IndicationsFatigue
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A